Search:

Steroid Profile: NORBOLETHONE (GENABOL)

By: Dane Fletcher HISTORY:
Designed in 1964 by Wyeth Laboratories in Philadelphia, PA, it is one of the oldest steroids, and was also not manufactured after design. In fact, Norbolethone was given in clinical trials over 30 years ago and never given the green light. No supply was ever manufactured, and no test was ever developed to detect this substance, yet ironically, it was suspected of being used in the 2000 Olympics based on blood and urine assays done by the IOC. Still, by the time testing was ready, athletes suspected of doping with it, had moved on. So where was the supply coming from, anyhow?
The mystery of Norbolethone is simple: When a steroid doesn't appear on a banned list, but does appear in the PDR, and there is no test in existence to detect it because it isn't in commercial production, a market is born. Loopholes in the world of sport and performance are rare and few since Congress began banning anabolic steroids, and laws began tightening the loop behind the mandate with each passing year. But just as a market develops quickly, so too does a test and a the appearance of a governing body to administer the test.
COMPOSITION/ ACTION:
Norbolethone is in the 19-Nor substance category. Other drugs in that category include Durabolin and Deca-Durabolin. Like Deca and other 19-Nors, this one has a low propensity for estrogenic activity or aromatization - a desirable effect for men and women alike. This is because it has weaker androgenic properties, and more anabolic properties. This is a drug many men and women would have taken, had it been manufactured since it's creation in 1964. However, designer markets have sprung up for this drug since its public debut, by accident, surrounding the doping scandal of the 2000 Sydney Olympics. Slow, sustained gains are the earmark of this drug
CYCLE TYPE AND LENGTH:
A cycle of 8-12 weeks is common. with injections about 2x weekly between 300-600mg/week. Just remember that it has optimum effectiveness if taken at a dose of 2mg per pound of lean body mass per week. Women should take around 50mg/ weekly.
SIDE EFFECTS:
Since its side effects fall in the 19-NOR category, it does not have a tendency to convert easily to estrogen and will not break down to a metabolite in androgen target tissue. It has a low propensity to create side effects such as oily skin, hair growth or acne because its metabolites are weaker than other 19-Nors and the resulting reductase produced is dihydronandrolone (just as it is with Deca). There is some progestin activity with this drug. Progestin (c-19) activity lends itself to negatives such as intensifying certain side effects, including enhanced fat storage, gynecomastia and liver disease (all estrogenic activity associated side effects).
Lest you believe there is no real problem with it, however, we will say this: Women experience a great deal of virilization with Deca, so this drug is no exception. Although, in some cases, the odd woman sees nothing from this and will see virilization from drugs such as Winstrol. Also, endogenous testosterone levels are of concern with this drug; particularly after longish cycles. In other words, it may be difficult to restart your own testosterone production if you do not think ahead with bridging of Clomid, HCG and anti-estrogens. Use HCG in 3 injections of about 4000 i.u.'s over the course of 5 to 7 days, spaced evenly.
COMMENTARY:
Stack with D-bol or other highly anabolic oral. You may also see great benefit, pre-contest, from stacking with Winstrol or a non-aromatizing androgen such as Trenbolone. Conclusion? This blip on the radar screen may be produced more and more as time goes by, and supplies of Deca or Durabolin are scarce.

Article Source: http://www.lifeweightloss.com

Dane Fletcher is THE Training Authority and writes exclusively fro SteroidPimp.com, a leading provider of weightlifting supplements and alternatices to anabolic steroids. For more information please visit www.steroidpimp.com

Please Rate this Article

Not yet Rated